2178 Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices 

The last notification was filed with 

the Department on October 5, 2021. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on October 22, 2021 (86 FR 58690). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–00613 Filed 1–12–22; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—The Integrated Photonics 

Institute for Manufacturing Innovation 

Operating Under the Name of the 

American Institute for Manufacturing 

Integrated Photonics 

Notice is hereby given that, on 

November 23, 2021, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), the 

Integrated Photonics Institute for 

Manufacturing Innovation operating 

under the name of the American 

Institute for Manufacturing Integrated 

Photonics (‘‘AIM Photonics’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

Regents of the University of Minnesota, 

Minneapolis, MN; Buhler Inc. Leybold 

Optics, Cary, NC; and Spark Photonics 

Design, Inc., Waltham, MA, have been 

added as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and AIM 

Photonics intends to file additional 

written notifications disclosing all 

changes in membership. 

On June 16, 2016, AIM Photonics 

filed its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on July 25, 2016 (81 FR 

48450). 

The last notification was filed with 

the Department on August 19, 2021. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on October 5, 2021 (86 FR 55001). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–00581 Filed 1–12–22; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Medical Technology 

Enterprise Consortium 

Notice is hereby given that, on 

November 29, 2021, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Medical Technology Enterprise 

Consortium (‘‘MTEC’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Integration Innovation Inc., 

Huntsville, AL; HackerOne, San 

Francisco, CA; Advanced Materials and 

Devices, Inc., Reno, NV; Cimarron 

Software Services Inc.,Houston, TX; 

Delta Chase LLC., West Chester, OH; 

Virginia Commonwealth University, 

Richmond, VA; H&H Medical 

Corporation, Williamsburg, VA; 

Spectrohm Inc. Tysons Corner, VA; 

Rubix LS, Lawrence, MA; University of 

Florida, Gainesville, FL; Phagelux 

(Canada) Inc., Montre ́al, CAN; Next 

Science, LLC., Jacksonville, FL; 

BlackBox Biometrics, Inc. (B3) 

Rochester, NY; VitaCyte LLC., 

Indianapolis, IN; Synedgen, Inc., 

Claremont, CA; KeriCure Medical, 

Wesley Chapel, FL; Kurve Technology 

Inc., Lynnwood,WA; SweetBio, Inc. 

Memphis, TN; DLH Silver Spring, MD; 

Novel Technologies Holdings Limited, 

Manchester, NH; KERECIS Limited, 

Isafjordur, ISL; NanoOxygenic LLC., 

Dallas, PA; Georgia State University 

Research Foundation, Inc. Atlanta, GA; 

Retia Medical LLC., Valhalla, NY; 

AivoCode Inc. La Jolla, CA; Medical 

Informatics Corp., Houston, TX; 

Technatomy Corporation Fairfax, VA; 

Terida LLC. Pinehurst, NC; Appili 

Therapeutics, Inc., Halifax, CAN; 

Continuous Precision Medicine(CPM) 

Research, Triangle Park, NC; Overseas 

Strategic Consulting, Ltd, Philadelphia, 

PA; Vizbii Technologies, Inc., 

Charleston, SC; Anthem Engineering 

LLC., Elkridge,MD; Perfusion Medical, 

LLC. Reston, VA; New York University, 

New York, NY; Catharsis Productions, 

Chicago,IL; University of New 

Hampshire Durham, NH; Aldyn, Boston, 

MA; GEN–AVIV LLC., North Miami 

Beach, FL; NeuroFlow, Inc., 

Philadelphia, PA; Advancement 

Strategy, LLC., Columbia, MD.; Belle 

Artificial Intelligence Corporation, 

Cambridge, MA; Diagnoss Inc, Pomona, 

CA; San Diego State University, San 

Diego, CA; Dovel Technologies, 

McLean, VA; ASSURSEC, LLC., 

LEESBURG, VA; Rhode Island Hospital, 

Providence, RI; University of 

Connecticut, Storrs, CT; Alertgy, Inc. 

MELBOURNE, FL; Boston University, 

Boston, MA; MBio Diagnostics, Inc. dba 

LightDeck Diagnostics, Boulder, CO; 

Pacific Institute for Research and 

Evaluation, Beltsville, MD; Tactical 

Medical Solutions, LLC., Anderson, SC; 

ViiNetwork, Inc., ViiMed, Washington, 

DC; Renaissance Biotech, LLC., Malibu, 

CA; Bio1 Systems, Inc., San Carlos, CA; 

DataRobot, Boston, MA; Knowesis Inc., 

Fairfax, VA; MassBiologics of the 

UMMS, Boston, MA; SOLUTE Inc., San 

Diego, CA; Aktiv Pharma Group, 

Broomfield, CO; Bettermeant, Inc., 

Berkeley, CA; SanMelix Laboratories, 

Inc., Hollywood, FL; Viscus Biologics 

LLC., Cleveland, OH; Guidehouse Inc. 

Falls Church, VA; Movement Rx 

Physical Therapy, P.C., San Diego, CA; 

Promethean LifeSciences, Inc., 

Pittsburgh, PA; Tygrus LLC., Troy, MI; 

MiMedx Group, Inc., Marietta, GA; 

Neomatrix Therapeutics, Inc., Stony 

Brook, NY; PuraLab LLC., Wilsonville, 

OR; InterSystems Corporation, 

Cambridge, MA; Full Spectrum Omega, 

Inc., Los Angeles, CA; Rockland 

Technimed Limited, Mahwah, NJ; 

MediWound, Ltd., Yavne, ISR; 

Primmune Therapeutics, Inc., San 

Diego, CA; Western Michigan University 

Homer Stryker M.D. School of 

Medicine, Kalamazoo, MI; Emmes 

Company LLC., Rockville MD; Canvas 

Incorporated, Huntsville, AL; Purgo 

Scientific, LLC., South Jordan, UT; 

Dascena, Houston, TX; Through The 

Cords LLC., Salt Lake City, UT; Armed 

Forces Services Corporation dba 

Magellan Federal, Arlington, VA; 

Immuron Limited, Victoria, AUS; 

Terumo BCT Biotechnologies, LLC., 

Lakewood, CO; TourniTek, Seattle, WA; 

West Therapeutic Development, LLC., 

Northbrook, IL; Maryland Development 

Center, Baltimore, MD; Tessonics 

Medical Systems Inc., BIRMINGHAM, 

MI; Vir Biotechnology, San Francisco, 

CA; Wound Exam Corp., Beverly Hills, 

CA; Creare LLC., Hanover, NH; Drexel 


jspears on DSK121TN23PROD with NOTICES1